zepbound/tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Lilly releases Zepbound® (tirzepatide) single-dose

Beneficial Antioxidant Protection Enhances Alertness And Mental Focus Supports Energy Metabolism In The Brain Keeps Nerves Healthy And In Repair Decreases Free Radical Production In The Brain

We're just a phone call away

Eur J Pharmacol 769:5563 Chiou WF, Chen J, Chen CF (1998) Relaxation of corpus cavernosum and raised intracavernous pressure by berberine in rabbit

FDA's new draft meeting roster gives us a much clearer picture:[5] Eleven standing voting members are listed: Gabriel Alizaidy, Asare Christian, Timothy Fensky, Bobby Harshbarger, Melissa Loseke, Haleem Mohammed, David Pope, Elizabeth Rebello, Brian Serumaga, Joshua Starbuck, and Kris Wusterhausen